IRCT20101018004961N12招募中3 期
Investigating the efficacy of oral propranolol in prevention of severe Retinopathy of Prematurity : A Randomized Clinical Trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 28 days 至 120 days（—）
- 性别
- All
入选标准
- •newborns with gestational age =34 weeks or birth weight =2000?g
- •with retinopathy of prematurity stage I or II
排除标准
- •Infants with congenital anomalies
- •heart diseases except PDA
- •recurrent bradycardia
- •eye malformations
- •acute renal failure
- •IVH grade II and III,
- •acute sepsis
研究者
相似试验
已完成
不适用
Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity (PROP-ROP)Retinopathy of prematurity (ROP), the leading cause of blindness in childrenNeonatal DiseasesOther retinal disordersISRCTN18523491A. Meyer University Children's Hospital (Italy)44
招募中
不适用
Clinical study of oral propranolol treatment for infantile hemangiomasinfantile hemangiomasJPRN-UMIN000004604niversity of Tokyo30
已完成
不适用
Clinical study of oral propranolol treatment for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangiomaJPRN-UMIN000004453Gifu University Graduate School of Medicine50
已完成
2 期
Oral propranolol and retinopathy of prematurityRetinopathy of prematurityIRCT20100512003915N21Tabriz University of Medical Sciences72
尚未招募
2 期
Propranolol and hemodynamics and sedatioIRCT20210614051574N1Esfahan University of Medical Sciences72